Improvements in muscle pain and the immune score were significant after four weeks ( p < 0.05), while improvements in the cognitive score and headache did not reach statistical significance.
← all excerpts
Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated ß2-Adrenergic Receptor Autoantibodies-An Interim Report.
1
—
—